Developer docs
API playgroundTry for free, no card

Search company profiles

Artimmune

Full company profile

uuid002e5ja

Namestring
Artimmune
Legal namestring
Artimmune
Websiteurl
artimmune.com
Company typeenum
Private
Founded yearint
2009
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersOrléans, France
HQ citystring
Orléans
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preclinical CRO services, immunology drug discovery, inflammation research, lung disease models, in vivo studies
Industry2 codes
PRIMARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Preclinical Contract Research
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Contract Research Services (CRO)
TypeProfessional Services
Description

Fee-for-service preclinical research contracts providing consulting, study design, execution, and reporting for immunology and inflammation drug discovery programs. Revenue generated through project-based contracts with pharma and biotech clients.

artimmune.com
2Consulting Services
TypeProfessional Services
Description

Expert scientific consulting in immunology, inflammation, and lung diseases for drug discovery programs.

artimmune.com
3Subcontracting Services
TypeProfessional Services
Description

Specialized subcontracting services for preclinical studies requiring specific expertise in immunology and respiratory disease models.

artimmune.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Artimmune is a French contract research organization (CRO) that offers consulting, preclinical research, and subcontracting services in immunology and inflammation, with an emphasis on lung diseases. The company provides in vivo and in vitro preclinical studies, validated respiratory disease models, biomarker strategies, and analytical services to pharmaceutical and biotechnology clients advancing drug discovery programs.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Artimmune is a preclinical Contract Research Organization (CRO) offering a unified portfolio of drug discovery services for inflammation and infection, with particular expertise in immunology and lung diseases. The core offering comprises In Vivo Services (preclinical disease models and functional assessments including plethysmography, bronchoalveolar lavage, histology, and immunohistochemistry) and In Vitro Services (primary cell assays, cytokine profiling, and flow cytometry). These services are supported by a Technology Platform with validated respiratory models and analytics, and a Preclinical Equipments portfolio. The company operates as a single integrated service provider rather than a modular software platform, delivering end-to-end preclinical research from model development through biomarker analysis.

Product and service5 records
1In Vivo Services
CategoryPreclinical Research Services
Description

Preclinical investigations of lung functions in vivo including plethysmography, bronchoalveolar lavage (BAL), cytology, histology, immunohistochemistry, and analysis of biochemical, immunological and molecular parameters. Disease models cover allergic asthma, chronic bronchitis, lung fibrosis, emphysema, ARDS, psoriasis, wound healing, atopic dermatitis, IBD, Pseudomonas aeruginosa and influenza A virus infection. Target users are pharma and biotech drug discovery teams.

2In Vitro Services
CategoryPreclinical Research Services
Description

Predictive ex vivo and in vitro assays providing primary cell assays, cytokine/chemokine profiling, flow cytometry, and pathway interrogation to support mechanism of action (MoA) and candidate ranking. Integrates high-content analysis and translational biomarker packages aligned with regulatory expectations. Target users are pharma and biotech drug discovery teams.

3Technology Platform
CategoryPreclinical Research Platform
Description

Validated respiratory models combined with state-of-the-art analytics ensuring sensitivity to pharmacodynamic effects. Supports plethysmography, BAL, imaging, and immunoassays for preclinical studies. Target users are drug discovery teams requiring reproducible preclinical endpoints.

4Preclinical Equipments Portfolio
CategoryPreclinical Research Equipment
Description

Portfolio of preclinical research equipment supporting plethysmography, bronchoalveolar lavage (BAL), imaging, and immunoassays used in client preclinical studies.

5Preclinical CRO Services
CategoryPreclinical Research Services
Description

Overall contract research organization offering consulting, preclinical research and subcontracting services in immunology and inflammation with an emphasis on lung diseases, including protocol design, biostatistics, and reporting to accelerate go/no-go decisions for pharma and biotech clients.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Artimmune results from a partnership between Key-Obs and the laboratory of Immunology INEM - UMR7355 - CNRS. This partnership established relevant experimental models of lung diseases proposed in an expert environment for preclinical drug discovery.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with the laboratory of Immunology INEM - UMR7355 - CNRS (CNRS and University of Orléans, France) has allowed establishment of relevant experimental models of lung diseases for preclinical research services.

Strategic tierMinorTypeOthers
Description

Artimmune is a member of the French Association AFSSI Sciences de la Vie, a professional association for life sciences companies in France.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Parent organization of Artimmune and a French preclinical CRO offering pharmacology and toxicology services. Highly comparable given shared ownership, overlapping services, and similar customer base in pharma and biotech.

TypeBroad incumbent
Description

Large CRO offering preclinical research, biomarkers, and clinical development services. Overlaps with Artimmune in preclinical inflammation and respiratory pharmacology as part of a much broader portfolio.

TypeDirect peer
Description

European preclinical CRO offering in vivo pharmacology and toxicology including respiratory and inflammation models. Comparable as a regional specialist CRO serving pharma and biotech preclinical programs.

TypeEmerging player
Description

Preclinical CRO providing in vitro and in vivo services including inflammation and immune-related assays. Comparable as a growing specialty CRO with overlapping assay and disease-model capabilities in the same therapeutic area.

TypeBroad incumbent
Description

Contract research services provider with preclinical, toxicology, and research models capabilities. Comparable in offering outsourced preclinical services though operating at broader scale across multiple therapeutic areas.

TypeBroad incumbent
Description

Global CRO with extensive preclinical research, discovery, and safety assessment services including respiratory disease models. A broad incumbent competing in many of the same therapeutic areas though at vastly larger scale.

TypeBroad incumbent
Description

Large global CRO and life science testing platform with broad preclinical, immunology, and biomarker offerings. Overlaps with Artimmune through its preclinical discovery services but operates at substantially larger scale with broader portfolio.

TypeOthers
Description

French industry association representing life sciences service companies. Not a direct competitor but a relevant ecosystem peer as Artimmune is a member; useful comparability as a federation of similar French CROs and preclinical service providers.

TypeDirect peer
Description

French preclinical CRO specializing in pharmacology studies including respiratory and inflammation models. Closest geographic and capability match to Artimmune as a similarly sized specialist serving pharma and biotech preclinical needs.

TypeDirect peer
Description

Preclinical CRO focused on metabolic disease and pharmacology models, including respiratory and inflammation studies. Comparable as a similarly sized specialist preclinical CRO competing for outsourced respiratory pharmacology work.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Artimmune

Preclinical Contract Researchartimmune.com

Artimmune firmographics

Firmographics
Name
Artimmune
Legal name
Artimmune
Website
https://artimmune.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Artimmune industry classification

Industry
Product category
Preclinical Contract Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Keywords

  • Preclinical CRO services
  • Immunology drug discovery
  • Inflammation research
  • Lung disease models
  • In vivo studies

Where Artimmune is headquartered

Location

Headquarters

HQ city
Orléans
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Artimmune business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Contract Research Services (CRO): Fee-for-service preclinical research contracts providing consulting, study design, execution, and reporting for immunology and inflammation drug discovery programs. Revenue generated through project-based contracts with pharma and biotech clients.
  2. Consulting Services: Expert scientific consulting in immunology, inflammation, and lung diseases for drug discovery programs.
  3. Subcontracting Services: Specialized subcontracting services for preclinical studies requiring specific expertise in immunology and respiratory disease models.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Artimmune product offering

Product offering

Core offering

Artimmune is a French contract research organization (CRO) that offers consulting, preclinical research, and subcontracting services in immunology and inflammation, with an emphasis on lung diseases. The company provides in vivo and in vitro preclinical studies, validated respiratory disease models, biomarker strategies, and analytical services to pharmaceutical and biotechnology clients advancing drug discovery programs.

Product overview

Artimmune is a preclinical Contract Research Organization (CRO) offering a unified portfolio of drug discovery services for inflammation and infection, with particular expertise in immunology and lung diseases. The core offering comprises In Vivo Services (preclinical disease models and functional assessments including plethysmography, bronchoalveolar lavage, histology, and immunohistochemistry) and In Vitro Services (primary cell assays, cytokine profiling, and flow cytometry). These services are supported by a Technology Platform with validated respiratory models and analytics, and a Preclinical Equipments portfolio. The company operates as a single integrated service provider rather than a modular software platform, delivering end-to-end preclinical research from model development through biomarker analysis.

Differentiator

Problem solved

Functional benefit

Products and services

  • In Vivo Services Preclinical investigations of lung functions in vivo including plethysmography, bronchoalveolar lavage (BAL), cytology, histology, immunohistochemistry, and analysis of biochemical, immunological and molecular parameters. Disease models cover allergic asthma, chronic bronchitis, lung fibrosis, emphysema, ARDS, psoriasis, wound healing, atopic dermatitis, IBD, Pseudomonas aeruginosa and influenza A virus infection. Target users are pharma and biotech drug discovery teams.
  • In Vitro Services Predictive ex vivo and in vitro assays providing primary cell assays, cytokine/chemokine profiling, flow cytometry, and pathway interrogation to support mechanism of action (MoA) and candidate ranking. Integrates high-content analysis and translational biomarker packages aligned with regulatory expectations. Target users are pharma and biotech drug discovery teams.
  • Technology Platform Validated respiratory models combined with state-of-the-art analytics ensuring sensitivity to pharmacodynamic effects. Supports plethysmography, BAL, imaging, and immunoassays for preclinical studies. Target users are drug discovery teams requiring reproducible preclinical endpoints.
  • Preclinical Equipments Portfolio Portfolio of preclinical research equipment supporting plethysmography, bronchoalveolar lavage (BAL), imaging, and immunoassays used in client preclinical studies.
  • Preclinical CRO Services Overall contract research organization offering consulting, preclinical research and subcontracting services in immunology and inflammation with an emphasis on lung diseases, including protocol design, biostatistics, and reporting to accelerate go/no-go decisions for pharma and biotech clients.

Companies that use Artimmune

Customer profile

Segments3 records

Ideal customer profiles3 records

Artimmune technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Artimmune partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Key-ObscoreStrategic or Co-development PartnerArtimmune results from a partnership between Key-Obs and the laboratory of Immunology INEM - UMR7355 - CNRS. This partnership established relevant experimental models of lung diseases proposed in an expert environment for preclinical drug discovery.
  • INEM - UMR7355 - CNRS (University of Orléans)coreStrategic or Co-development PartnerPartnership with the laboratory of Immunology INEM - UMR7355 - CNRS (CNRS and University of Orléans, France) has allowed establishment of relevant experimental models of lung diseases for preclinical research services.
  • AFSSI Sciences de la VieminorOthersArtimmune is a member of the French Association AFSSI Sciences de la Vie, a professional association for life sciences companies in France.

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Artimmune competitors and assessment

Company assessment

Direct peers

  • Key-Obs: Parent organization of Artimmune and a French preclinical CRO offering pharmacology and toxicology services. Highly comparable given shared ownership, overlapping services, and similar customer base in pharma and biotech.
  • Scantox (formerly CiToxLAB): European preclinical CRO offering in vivo pharmacology and toxicology including respiratory and inflammation models. Comparable as a regional specialist CRO serving pharma and biotech preclinical programs.
  • Porsolt: French preclinical CRO specializing in pharmacology studies including respiratory and inflammation models. Closest geographic and capability match to Artimmune as a similarly sized specialist serving pharma and biotech preclinical needs.
  • Physiogenex: Preclinical CRO focused on metabolic disease and pharmacology models, including respiratory and inflammation studies. Comparable as a similarly sized specialist preclinical CRO competing for outsourced respiratory pharmacology work.

Broad incumbents

  • Labcorp Drug Development (Covance): Large CRO offering preclinical research, biomarkers, and clinical development services. Overlaps with Artimmune in preclinical inflammation and respiratory pharmacology as part of a much broader portfolio.
  • Inotiv: Contract research services provider with preclinical, toxicology, and research models capabilities. Comparable in offering outsourced preclinical services though operating at broader scale across multiple therapeutic areas.
  • Charles River Laboratories: Global CRO with extensive preclinical research, discovery, and safety assessment services including respiratory disease models. A broad incumbent competing in many of the same therapeutic areas though at vastly larger scale.
  • Eurofins Scientific: Large global CRO and life science testing platform with broad preclinical, immunology, and biomarker offerings. Overlaps with Artimmune through its preclinical discovery services but operates at substantially larger scale with broader portfolio.

Emerging players

  • Reaction Biology Corporation: Preclinical CRO providing in vitro and in vivo services including inflammation and immune-related assays. Comparable as a growing specialty CRO with overlapping assay and disease-model capabilities in the same therapeutic area.

Others

  • AFSSI Sciences de la Vie: French industry association representing life sciences service companies. Not a direct competitor but a relevant ecosystem peer as Artimmune is a member; useful comparability as a federation of similar French CROs and preclinical service providers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights5 records

Customer concentration

Artimmune social profiles

Digital presence

Artimmune financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Artimmune leadership team

Management profile

Number of profiles

Artimmune funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Artimmune M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Artimmune

What does Artimmune do?

Artimmune is a French contract research organization (CRO) that offers consulting, preclinical research, and subcontracting services in immunology and inflammation, with an emphasis on lung diseases. The company provides in vivo and in vitro preclinical studies, validated respiratory disease models, biomarker strategies, and analytical services to pharmaceutical and biotechnology clients advancing drug discovery programs.

Is Artimmune a public or private company?

Artimmune is a private company. It is classified as corporate owned and is currently operating.

When was Artimmune founded?

Artimmune was founded in 2009. It employs 1 to 10 people.

Where is Artimmune based?

Artimmune is headquartered in Orléans, France, in the Europe region.

How does Artimmune make money?

Three revenue lines are on record. Contract Research Services (CRO) is the primary driver. The others are consulting Services and subcontracting Services.

Who are Artimmune's main competitors?

Direct peers on record are Key-Obs, Scantox (formerly CiToxLAB), Porsolt and Physiogenex. Broad incumbents are Labcorp Drug Development (Covance), Inotiv, Charles River Laboratories and Eurofins Scientific. Reaction Biology Corporation is listed as an emerging player. AFSSI Sciences de la Vie is listed as an others.

Does Artimmune have an API?

No public API is recorded for Artimmune.

What industry is Artimmune in?

Artimmune's product category is Preclinical Contract Research. Its primary akta.pro industry code is HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales